Nanz Med Science Pharma Private Limited, a active private limited company, was established on 19 December 2006 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100DL2006PTC156756. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹12.11 Cr.
It upholds a compliant status. Employing 450 professional, Its leadership includes Manmit Singh Malhotra (Managing Director), Harpreet Singh Puri (Additional Director), Sunpreet Kaur Puri (Additional Director). Past directors included Manmit Singh Malhotra, Rakesh Bajaj, Inderjit Malik. It holds ₹105.15 Cr open charges and ₹46.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-168 Ground Floor, Naraina Industrial Area, Phase I, New Delhi, Delhi, 110028.
U24100DL2006PTC156756
156756
19 December 2006
₹15.00 Cr
₹12.11 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nanz Med Science Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manmit Singh Malhotra | Managing Director | 01 Apr 2009 | Current |
| Harpreet Singh Puri | Additional Director | 15 Nov 2024 | Current |
| Sunpreet Kaur Puri | Additional Director | 15 Nov 2024 | Current |
| Lakhvinder Pal Singh | Director | 01 Oct 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Aug 2024 | Past |
| Pramod Abcsdd | Additional Director | 21 Jan 2022 | Past |
| Pramod Abcsdd | Director | 19 Nov 2018 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 09 Feb 2008 | Past |
| Pramod Abcsdd | Director | 01 Oct 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nanz Med Science Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 22.49% increase. The company also saw a substantial improvement in profitability, with a 138.8% increase in profit. The company's net worth Soared by an impressive increase of 16.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Nanz Med Science Pharma had a promoter holding of 86.50% and a public holding of 13.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,051,457,423.00
₹465,043,093.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2025 | Hdfc Bank Limited | ₹0.85 M | Open |
| 23 Dec 2024 | Others | ₹6.00 Cr | Open |
| 15 Jan 2024 | Hdfc Bank Limited | ₹2.81 M | Open |
| 18 Dec 2023 | Tata Capital Financial Services Limited | ₹3.00 Cr | Open |
| 15 Nov 2023 | Hdfc Bank Limited | ₹4.40 M | Open |
Explore comprehensive loan charge details -
Nanz Med Science Pharma has a workforce of 450 employees as of Mar 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nanz Med Science Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nanz Med Science Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.09 Cr with Charge ID 101184304 was registered on 10 Nov 2025. was completed.
The activity A charge with Hdfc Bank Limited of Rs. 90.05 Cr registered on 04 Feb 2016 with Charge ID 10620352 was modified on 31 Jul 2025. was completed.
Progress on A charge with Others amounted to Rs. 6.00 Cr with Charge ID 101041345 was registered on 23 Dec 2024. was documented.
The activity Harpreet Singh Puri was appointed as a Additional Director was appointed as a Additional Director on 15 Nov 2024 & has been associated with this company since 1 year 1 month . was completed.
Progress on Sunpreet Kaur Puri was appointed as a Additional Director was appointed as a Additional Director on 15 Nov 2024 & has been associated with this company since 1 year 1 month . was documented.
Progress on Nanz Med Science Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Nanz Med Science Pharma Private Limited is U24100DL2006PTC156756.
Nanz Med Science Pharma Private Limited is headquartered at C-168 Ground Floor, Naraina Industrial Area, Phase I, New Delhi, Delhi, 110028.
Nanz Med Science Pharma Private Limited was incorporated on 19 December 2006.
The current directors of Nanz Med Science Pharma Private Limited are
The primary industry of Nanz Med Science Pharma Private Limited is Manufacturing.
Nanz Med Science Pharma Private Limited is unlisted.
The authorized capital of Nanz Med Science Pharma Private Limited is ₹15.00 Cr, and the paid-up capital is ₹12.11 Cr.
The compliance status of Nanz Med Science Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX